🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The main purpose of this study is to investigate the safety of prexasertib ...
Status
Completed
Location
Florida Cancer Specialists
Start Date
2014-06-18
Trial ID
NCT02124148
Treatments Being Tested
This is a phase 1b/2 study to evaluate the safety and efficacy of metronomi...
Status
Withdrawn
Location
Multiple Locations
Start Date
2017-12
Trial ID
NCT03169764
The purpose of this study is to learn about the safety and effects of the s...
Status
Terminated
Location
Highlands Oncology Group
Start Date
2024-12-10
Trial ID
NCT06704724
Due to the increase of tumor control rate and survival rate in era of IMRT,...
Status
Unknown
Location
Multiple Locations
Start Date
2018-06-12
Trial ID
NCT03529279
Treatments Being Tested
The primary end point of the study is confirmed objective response rate (co...
Status
Unknown
Location
Kun Huei Yeh, Ph.D
Start Date
2006-06
Trial ID
NCT00384878
Treatments Being Tested
The purpose of this study is to learn about the safety and effects of the s...
Status
Active Not Recruiting
Location
Highlands Oncology Group, PA
Start Date
2024-06-27
Trial ID
NCT06447662
This is a phase 1b/2 study to evaluate the safety and efficacy of metronomi...
Status
Terminated
Location
Chan Soon-Shiong Institute for Medicine
Start Date
2018-01-09
Trial ID
NCT03387111
RATIONALE: Drugs used in chemotherapy work in different ways to stop the gr...
Status
Completed
Location
Norwalk Hospital
Start Date
2006-09-15
Trial ID
NCT00381706
This study intends to evaluate the feasibility and treatment efficacy of ad...
Status
Completed
Location
NYU Cancer Center
Start Date
2005-07
Trial ID
NCT00857246
This is a Phase 1B/2, non-randomized, dose-escalation, multicenter, open-la...
Status
Terminated
Location
Multiple Locations
Start Date
2009-09-25
Trial ID
NCT00954512